Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Lupus Patients Have More Lethal Form of Kidney Disease

Sue Pondrom  |  April 13, 2011

Children and adults with end-stage renal disease (ESRD) secondary to systemic lupus erythematosus (SLE) have a higher risk of death than those with other types of kidney disease, according to a study by Sule et al.1

Based on an analysis of United States Renal Data System records from more than 98,000 children and adults with various forms of ESRD (not limited to SLE), the researchers found that kidney disease in children with SLE was more than twice (2.4 times) as lethal compared with pediatric patients with ESRD secondary to other causes. Adult SLE patients had a 1.7 times–higher risk of dying than adults with other forms of ESRD.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In both pediatric and adult SLE populations, the vast majority of deaths were attributed to cardiovascular disease; however, the affects were primarily noted in children. Three quarters of the children with SLE kidney disease who died did so from heart problems, mostly heart attacks. By comparison, only 26% of children with nonlupus kidney disease died from heart problems.

The researchers said that SLE triggers chronic inflammation and that lupus patients seem more likely to develop hypertension and high cholesterol at an unusually early age. “Inflammation may play a pathological role in the development of cardiovascular disease,” they commented, adding that “an increased inflammatory state leading to atherosclerosis may account for the much young age at death for the adult patients with ESRD secondary SLE compared with other patients.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“What we may be seeing here is a double whammy of cardiovascular damage—on the one hand, there’s the damage caused by lupus itself, further compounded by the resulting kidney disease,” said lead investigator Sangeeta Sule, MD, PhD, a pediatric nephrologist and SLE expert at Johns Hopkins Childrens Center in Maryland, in a news release.

While 75% of deaths in children were attributed to heart disease, 25% were attributed to septicemia/infections. These causes accounted for half of deaths in adults with ESRD secondary to SLE, as well—30% from cardiovascular disease and 20% from infections. In adult and pediatric patients with other causes of ESRD, cardiovascular disease and infections were also common causes of death, at 25% and 8% of adult deaths and 26% and 12% of pediatric deaths, respectively.

Rheumatologists Weigh In

“It would be interesting to see if there is a difference in mortality rates among the adult onset dialysis patients with SLE if their SLE began before or after age 18,” according to a written comment to The Rheumatologist from rheumatologists Anne Eberhard, MD, of North Shore-Long Island Jewish Health System, and Emily von Scheven, MD, of the University of California, San Francisco.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:Renal diseaseResearchSystemic lupus erythematosus

Related Articles

    Pediatric Rheumatologist Shortage Spurs Need for Adult Specialists to Treat Children with Rheumatic Conditions

    February 15, 2017

    WASHINGTON, D.C.—Addressing a gathering of healthcare providers at the 2016 ACR/ARHP Annual Meeting concurrent session titled, Pediatric Rheumatology for the Adult Rheumatologist, part of the ACR Review Course, expert Sangeeta Sule, MD, PhD, associate professor of pediatrics specializing in rheumatology at Johns Hopkins Hospital in Baltimore, displayed a color-coded map of the U.S. on which…

    A&R Abstracts – HMGB1

    August 1, 2011

    For Further Reading

    Mortality Trends in Lupus Nephritis

    February 28, 2019

    According to results of a recent study of all-cause and cause-specific mortality trends of end-stage renal disease due to lupus nephritis from 1995 to 2014, the all-cause premature mortality rate improved among white, African American and Hispanic patients, with reduced risk of death from CVD and infection. Jorge et al. observed a 32% reduction in mortality. This improved survival may be explained by a combination of improvements in the management of ESRD and of underlying SLE…

    Tips for Transitioning Patients from Pediatric to Adult Rheumatology Care

    October 14, 2021

    Approximately 50% of young adult patients with childhood-onset rheumatic diseases become lost to follow-up within the first year of transferring to adult rheumatology care, mirroring the statistics of other subspecialties.1,2 One of the challenges cited most consistently by young adult patients and their families relates to differences between rheumatology care delivery in the pediatric and…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences